| Drug Name | Norethindrone | 
							
								| Drug ID | BADD_D01585 | 
							
								| Description | Norethisterone, also known as norethindrone, is a synthetic progestational hormone belonging to the 19-nortestosterone-derived class of progestins.[A10367] It is further classified as a second-generation progestin, along with [levonorgestrel] and its derivatives, and is the active form of several other progestins including [norethynodrel] and [lynestrenol].[A10367] Norethisterone mimics the actions of endogenous [progesterone], albeit with a greater potency,[A188075] and is used on its own or in combination with estrogen derivatives in a variety of applications including contraception and hormone replacement therapy.[L9527,L10301,L10304,L10307] First derived in 1951 in Mexico City, norethisterone was originally intended for use as a remedy for irregular menstruation and endometriosis, and was not marketed for use as an oral contraceptive until 1962.[L10439] | 
							
								| Indications and Usage | Norethisterone is indicated as an oral contraceptive when given as monotherapy[L9527] or in combination with an estrogen component, such as [ethinylestradiol] or [estradiol].[L10313,L10307] In combination with an estrogen component, oral norethisterone is also indicated as a hormone replacement therapy in the treatment of postmenopausal osteoporosis and moderate-to-severe vasomotor symptoms arising from menopause.[L10304] When applied via transdermal patch, the combination of norethisterone and estradiol is indicated for the treatment of hypoestrogenism, vulvovaginal atrophy, and moderate-severe vasomotor symptoms.[L10301]
Norethisterone, taken in combination with intramuscular [leuprolide], is also indicated for the symptomatic treatment of endometriosis-related pain.[L10310] | 
							
								| Marketing Status | approved | 
				
							
								| ATC Code | G03DC02; G03AC01 | 
							
								| DrugBank ID | DB00717 | 
							
								| KEGG ID | D00182 | 
							
								| MeSH ID | D009640 | 
							
								| PubChem ID | 6230 | 
							
								| TTD Drug ID | D0GL7U | 
							
								| NDC Product Code | 51862-886; 68180-876; 68462-303; 68462-305; 0378-7272; 68180-877; 50090-6161; 0378-7292; 70518-3113; 79929-015; 30007-829; 60870-0235; 16714-440; 63187-748; 51862-884; 52544-629; 65862-925; 69238-1583; 53002-1793; 59651-136; 65162-475; 71205-526; 50102-300; 16714-441; 42291-650 | 
							
								| UNII | T18F433X4S | 
							
								| Synonyms | Norethindrone | Norpregneninolone | Norethisterone | 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)- | Ethinylnortestosterone | Conceplan | Micronor | Norlutin | Nor-QD | Nor QD | NorQD | Norcolut | Norcolute | Norethindrone, (1 beta)-Isomer | Monogest |